Today we announce our results for the financial year to 30 April 2021.
The firm has seen a 12% increase in UK revenue to £175.5m and a 23% increase in UK profit to £71m. UK profit per equity partner is 18% up on last year.
UK Managing Partner, Shane Gleghorn, said: "Our focus this financial year has been our people and clients, and these pleasing results are attributable to their commitment to the firm. We anticipated, and had, a slow start to our financial year due to the contraction caused by the onset of the pandemic. We were confident, however, that the focus of our sector and practice groups positioned us well for a significant uptick in activity coming out of the second quarter, and that proved to be the case. That has resulted in the firm recording the highest ever revenue and profit for the UK business, which is a credit to our people. We saw the onset of our investment strategy in people and technology contributing to these strong results."
The firm has also recorded its highest ever global revenue, totalling £371.3 million. Taylor Wessing continues to strengthen its international platform and presence, with significant investment across its European offices and new on-the-ground operations announced this year in strategically prioritised jurisdictions such as Israel and Ireland.
Notes to editors
- Our 2019/20 financial results press statement
- Five senior promotions to the UK partnership announced in November 2020
- The firm announced its intention to open a new office in the Republic of Ireland in April 2021
- The firm attracted three new teams to the firm with key appointments from BCLP, Greenberg Traurig and Stephenson Harwood
- It was also a successful year for lateral partner hires, with significant appointments of International Head of Life Sciences Alison Dennis, Ross McNaughton from Penningtons, Ian Moore, Murray North and Matthew Swainston to name a few
- The firm continued to show its commitment to community and the arts through its support of Hold Still, the nationwide community project spearheaded by HRH The Duchess of Cambridge and the National Portrait Gallery
Some work highlights from FY2020/21:
- Advising on £300 million main market IPO of Digital 9 Infrastructure plc – April 2021
- Advising leading-edge life sciences companies on transformational roll-up and $114m crossover financing – March 2021
- Advising Jagex, one of the UK’s largest video game developers and publishers, on its sale – March 2021
- Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies – February 2021
- Advising UK fintech Curve on $95M funding round ahead of US launch – January 2021
- Advised international commercial real estate investment company EPIC, on the £335m sale of its portfolio of eight UK Logistics investment properties – January 2021
- Private Equity team ends 2020 strong with eight closed deals – January 2021
- Advising Accor on investment into AGO Hotels – December 2020
- Advising Monzo on its £60m fundraising – December 2020
- Advising on Africa's largest ever seed round for challenger bank Kuda – November 2020
- Advising on major healthcare sale of Nucleus Global to Huntsworth – November 2020
- Enabling the provision of e-waste services in Israel with Enviroserve – November 2020
- Advising BlackLine on $150 million acquisition of Rimilia Holdings – October 2020
- Advising EQT Real Estate on £1 billion joint venture for London – September 2020
- Advising Dawn Capital on US$100 million Series D round for Dataiku – August 2020
- Advising on the sale of Cambridge AI company SciBite to Elsevier – August 2020
- Closing $125m Series B funding for Thought Machine – July 2020
- Revolutionising crypto collectibles with Cryptograph's new digital auction house – July 2020
- Advising The Rohatyn Group on investment in Optimapharm d.d. – May 2020
